The patient initially presented with difficulty hearing and left ear pain, and noted to have a large pharyngeal mass prompting a work-up including a CT scan.
The patient was seen in clinic for evaluation of his pharyngeal cancer with possible biopsy.
Head CT performed in [**2196-3-24**] showed a 4 cm left tongue mass with positive lymphadenopathy.
The patient underwent a fine-needle aspiration consistent with squamous cell carcinoma.
PHYSICAL EXAMINATION:  Vital signs were temperature 98.2, blood pressure 110/70, heart rate 50, respiratory rate 16, 98% on room air.
Lungs:  Clear to auscultation bilaterally.
Cardiovascular:  Regular rate and rhythm with a 3/6 systolic ejection murmur, normal S1 and S2, no rubs or gallops.
LABORATORY DATA:  Complete blood count showed a white blood cell count of 7.9, hematocrit 39, MCV 88, platelet count 388.
Coagulation studies were PT 12.8, PTT 30.1, INR 1.1.
Chemistries showed a sodium of 143, potassium 3.7, chloride 102, bicarbonate 30, BUN 14, creatinine 1.1, glucose 117, albumin 3.4.
Urinalysis showed a specific gravity of 1.018, 20 white blood cells, moderate bacteria, negative nitrites, small leukocyte esterase.
CT of the neck ([**2196-4-7**]) showed a 4 cm mass at the tongue base left of midline with inferior extension to pre-epiglottic space, 1.4 cm lymph node lateral to the left carotid bifurcation.
Chest x-ray ([**2196-5-9**]) showed increased opacity of the right lower lobe.
A Port-a-Cath was placed on [**2196-5-16**] for initiation of chemotherapy.
On [**2196-5-24**] the patient's blood pressure was noted to have decreased into the 80s.
Chest x-ray at this time showed worsened opacification.
Sputum sample was sent and became positive for MRSA.
Throughout the rest of the patient's hospitalization, his blood pressure was stable and he was stable from a cardiovascular standpoint.
On [**2196-5-24**] the patient's chest x-ray showed worsened opacification and the following day MRSA grew out in his sputum.
On the following day the patient respiked a temperature to 103 and ceftazidime was discontinued at this time.
TSH was negative at that time.
b.i.d., hold for systolic blood pressure of less than 110, heart rate less than 60.
[**MD Number(1) 13799**]  Dictated By:[**Last Name (NamePattern1) 12216**] MEDQUIST36  D:  [**2196-6-3**]  10:27 T:  [**2196-6-3**]  10:42 JOB#:  [**Job Number 105652**]  cc:[**Name8 (MD) 105653**
